Log in
NYSE:BHC

Bausch Health Companies Stock Forecast, Price & News

$15.74
-0.30 (-1.87 %)
(As of 09/23/2020 12:00 AM ET)
Add
Compare
Today's Range
$15.62
Now: $15.74
$16.22
50-Day Range
$15.40
MA: $16.96
$20.13
52-Week Range
$11.15
Now: $15.74
$31.97
Volume4.93 million shs
Average Volume4.14 million shs
Market Capitalization$5.59 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.14
Bausch Health Companies Inc. develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through four segments: Bausch + Lomb/International, Salix, Ortho Dermatologics, and Diversified Products. The Bausch + Lomb/International segment offers products with a focus on the vision care, surgical, and consumer and ophthalmology Rx products in the United States; and Solta products, branded and generic pharmaceutical products, OTC products, and medical device products, and Bausch + Lomb products in Canada, Europe, Asia, Australia, Latin America, Africa, and the Middle East. The Salix segment provides gastroenterology products in the United States. The Ortho Dermatologics segment offers dermatological products in the United States; and Solta medical aesthetic devices internationally. The Diversified Products segment provides pharmaceutical products in the areas of neurology and other therapeutic classes, as well as generic and dentistry products in the United States. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. was founded in 1983 and is headquartered in Laval, Canada.
Read More
Bausch Health Companies logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.3Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.91 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone514-744-6792

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$8.60 billion
Cash Flow$10.29 per share
Book Value$3.22 per share

Profitability

Net Income$-1,788,000,000.00

Miscellaneous

Employees21,700
Market Cap$5.59 billion
Next Earnings Date11/2/2020 (Estimated)
OptionableOptionable
$15.74
-0.30 (-1.87 %)
(As of 09/23/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive BHC News and Ratings via Email

Sign-up to receive the latest news and ratings for BHC and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Bausch Health Companies (NYSE:BHC) Frequently Asked Questions

How has Bausch Health Companies' stock price been impacted by Coronavirus (COVID-19)?

Bausch Health Companies' stock was trading at $18.45 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, BHC shares have decreased by 14.7% and is now trading at $15.74.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Bausch Health Companies?

17 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Bausch Health Companies in the last year. There are currently 7 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Bausch Health Companies
.

When is Bausch Health Companies' next earnings date?

Bausch Health Companies is scheduled to release its next quarterly earnings announcement on Monday, November 2nd 2020.
View our earnings forecast for Bausch Health Companies
.

How were Bausch Health Companies' earnings last quarter?

Bausch Health Companies Inc (NYSE:BHC) issued its earnings results on Thursday, August, 6th. The company reported $0.46 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.66 by $0.20. The firm earned $1.66 billion during the quarter, compared to the consensus estimate of $1.79 billion. Bausch Health Companies had a negative net margin of 25.19% and a positive return on equity of 104.13%. Bausch Health Companies's quarterly revenue was down 22.7% on a year-over-year basis. During the same quarter last year, the business posted $1.07 EPS.
View Bausch Health Companies' earnings history
.

What guidance has Bausch Health Companies issued on next quarter's earnings?

Bausch Health Companies updated its FY 2020 Pre-Market earnings guidance on Thursday, August, 6th. The company provided EPS guidance of for the period. The company issued revenue guidance of $7.8-8 billion, compared to the consensus revenue estimate of $8.05 billion.

What price target have analysts set for BHC?

17 brokerages have issued 1-year price targets for Bausch Health Companies' shares. Their forecasts range from $18.00 to $50.00. On average, they expect Bausch Health Companies' stock price to reach $29.18 in the next twelve months. This suggests a possible upside of 85.4% from the stock's current price.
View analysts' price targets for Bausch Health Companies
.

Who are some of Bausch Health Companies' key competitors?

What other stocks do shareholders of Bausch Health Companies own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Bausch Health Companies investors own include Gilead Sciences (GILD), Micron Technology (MU), Constellation Software (CSU), Intact Financial (IFC), NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Bank of America (BAC), Tesla (TSLA) and Twitter (TWTR).

Who are Bausch Health Companies' key executives?

Bausch Health Companies' management team includes the following people:
  • Mr. Joseph C. Papa, CEO & Chairman (Age 64)
  • Mr. Paul S. Herendeen, Exec. VP & CFO (Age 63)
  • Mr. Thomas J. Appio, Pres & Co-Head Bausch + Lomb/International (Age 57)
  • Mr. William D. Humphries, Pres of Ortho-Dermatologics (Age 53)
  • Mr. Osama A. Eldessouky, Sr. VP, Controller & Chief Accounting Officer (Age 47)

What is Bausch Health Companies' stock symbol?

Bausch Health Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "BHC."

Who are Bausch Health Companies' major shareholders?

Bausch Health Companies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Paulson & CO. Inc. (7.28%), FIL Ltd (5.17%), Vanguard Group Inc. (2.59%), Kohlberg Kravis Roberts & Co. L.P. (1.47%), Bank of Montreal Can (1.31%) and Guardian Capital LP (0.86%). Company insiders that own Bausch Health Companies stock include Christina Ackermann, Eschenbach Andrew C Von, Holdings LP Valueact, John Paulson, Joseph C Papa, Mark C Mckenna, Schutter Richard U De, Thomas Appio and William D Humphries.
View institutional ownership trends for Bausch Health Companies
.

Which major investors are selling Bausch Health Companies stock?

BHC stock was sold by a variety of institutional investors in the last quarter, including FIL Ltd, Goldman Sachs Group Inc., Vanguard Group Inc., UBS Group AG, PDT Partners LLC, Gamco Investors INC. ET AL, Grantham Mayo Van Otterloo & Co. LLC, and State of Wisconsin Investment Board.
View insider buying and selling activity for Bausch Health Companies
.

Which major investors are buying Bausch Health Companies stock?

BHC stock was purchased by a variety of institutional investors in the last quarter, including Kohlberg Kravis Roberts & Co. L.P., Paulson & CO. Inc., Guardian Capital LP, Skandinaviska Enskilda Banken AB publ, FMR LLC, Canada Pension Plan Investment Board, Point72 Asset Management L.P., and Assenagon Asset Management S.A.. Company insiders that have bought Bausch Health Companies stock in the last two years include Christina Ackermann, Eschenbach Andrew C Von, Holdings LP Valueact, John Paulson, Joseph C Papa, Schutter Richard U De, Thomas Appio, and William D Humphries.
View insider buying and selling activity for Bausch Health Companies
.

How do I buy shares of Bausch Health Companies?

Shares of BHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Bausch Health Companies' stock price today?

One share of BHC stock can currently be purchased for approximately $15.74.

How big of a company is Bausch Health Companies?

Bausch Health Companies has a market capitalization of $5.59 billion and generates $8.60 billion in revenue each year. The company earns $-1,788,000,000.00 in net income (profit) each year or $4.43 on an earnings per share basis. Bausch Health Companies employs 21,700 workers across the globe.

What is Bausch Health Companies' official website?

The official website for Bausch Health Companies is www.bauschhealth.com.

How can I contact Bausch Health Companies?

Bausch Health Companies' mailing address is 2150 ST. ELZEAR BLVD. WEST, LAVAL A8, H7L 4A8. The company can be reached via phone at 514-744-6792 or via email at [email protected]

This page was last updated on 9/24/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.